Mounjaro / tirzepatide / weekly injection

Mounjaro online consultation: effects, side effects, doses, and prices

Mounjaro is a once-weekly tirzepatide injection. In Japan, its approved indication is type 2 diabetes. Use for weight management in private medical care is off-label and requires an individual medical assessment.

Dose pathway

The usual starting dose is 2.5mg. After 4 weeks, 5mg is normally used. If 5mg remains insufficient after at least 4 weeks and side effects are acceptable, 7.5mg may be considered. Escalation is not automatic.

Expected changes

Some people experience reduced appetite, earlier fullness, smaller portions, and improved glucose measures. Weight response varies with starting weight, diabetes status, diet, activity, sleep, alcohol, and treatment duration.

Dose differences

2.5mg

Starting dose used to assess tolerability.

5mg

Usual maintenance dose after 4 weeks.

7.5mg

Next escalation step when 5mg is insufficient and safe to increase.

When should 5mg be increased to 7.5mg?

Side effects and urgent signs

Common symptoms include nausea, constipation, diarrhea, reduced appetite, stomach discomfort, and vomiting. Seek urgent care for persistent severe abdominal pain, repeated vomiting, marked dehydration, jaundice, breathing difficulty, confusion, or severe hypoglycemia symptoms.

Prices

Dose1 month3 months6 months
2.5mg¥15,100¥42,600¥81,800
5mg¥23,900¥65,600¥127,000
7.5mg¥34,800¥94,800¥179,800

Tax included. There are no transition set plans. Each dose is prescribed separately after consultation.

Prescription is not guaranteed

The doctor may recommend staying at 5mg, reducing, delaying, stopping, or choosing another treatment.

Frequently asked questions

Can I start at 7.5mg?

Normally no. Treatment usually starts at 2.5mg and proceeds through 5mg.

Does everyone move from 5mg to 7.5mg?

No. If 5mg is effective or side effects remain, the doctor may continue 5mg.

What are the 7.5mg prices?

¥34,800 for 1 month, ¥94,800 for 3 months, and ¥179,800 for 6 months.